142 related articles for article (PubMed ID: 31602256)
1. Preoperative AFU Is a Useful Serological Prognostic Predictor for Colorectal Liver Oligometastasis Patients Undergoing Hepatic Resection.
Deng Y; Zhao Y; Fan W; Peng J; Luo X; Mo Y; Xiao B; Zhang L; Pan Z
J Cancer; 2019; 10(21):5049-5056. PubMed ID: 31602256
[No Abstract] [Full Text] [Related]
2. Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study.
Wang K; Guo W; Li N; Shi J; Zhang C; Lau WY; Wu M; Cheng S
Br J Cancer; 2014 Apr; 110(7):1811-9. PubMed ID: 24569461
[TBL] [Abstract][Full Text] [Related]
3. [Preoperative serum α-1-fucosidase as an early-recurrent indicator for hepatocellular carcinoma following curative resection].
Zhou Y; Ma X; Wu J; Zhang C; Wang B; Song B; Guo W; Pan B
Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(46):3623-8. PubMed ID: 25622951
[TBL] [Abstract][Full Text] [Related]
4. High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection.
Lu Z; Peng J; Wang Z; Pan Z; Yuan Y; Wan D; Li B
Med Oncol; 2016 Nov; 33(11):121. PubMed ID: 27722895
[TBL] [Abstract][Full Text] [Related]
5. Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma.
Yu X; Zhang R; Yang T; Zhang M; Xi K; Lin Y; Wen Y; Wang G; Huang Z; Zhang X; Zhang L
J Thorac Dis; 2019 Sep; 11(9):3980-3990. PubMed ID: 31656672
[TBL] [Abstract][Full Text] [Related]
6. Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer.
Ayude D; Páez De La Cadena M; Martínez-Zorzano VS; Fernández-Briera A; Rodríguez-Berrocal FJ
Oncology; 2003; 64(1):36-45. PubMed ID: 12457030
[TBL] [Abstract][Full Text] [Related]
7. Does the Preoperative Prognostic Nutritional Index Predict Survival in Patients with Liver Metastases from Colorectal Cancer Who Underwent Curative Resection?
Zhao Y; Deng Y; Peng J; Sui Q; Lin J; Qiu M; Pan Z
J Cancer; 2018; 9(12):2167-2174. PubMed ID: 29937936
[No Abstract] [Full Text] [Related]
8. Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival.
Peng J; Li H; Ou Q; Lin J; Wu X; Lu Z; Yuan Y; Wan D; Fang Y; Pan Z
Onco Targets Ther; 2017; 10():3789-3799. PubMed ID: 28794643
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Utility of Histological Growth Patterns of Colorectal Lung Oligometastasis.
Yeong SJ; Pak MG; Lee HW; Ha SY; Roh MS
J Pathol Transl Med; 2018 Mar; 52(2):98-104. PubMed ID: 29433159
[TBL] [Abstract][Full Text] [Related]
10. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.
Lu ZY; Cen C; Shao Z; Chen XH; Xu CF; Li YM
World J Gastroenterol; 2016 Feb; 22(5):1884-90. PubMed ID: 26855548
[TBL] [Abstract][Full Text] [Related]
11. Alpha-L-Fucosidase Serves as a Prognostic Indicator for Intrahepatic Cholangiocarcinoma and Inhibits Its Invasion Capacity.
Shuang Z; Mao Y; Lin G; Wang J; Huang X; Chen J; Duan F; Li S
Biomed Res Int; 2018; 2018():8182575. PubMed ID: 29682557
[TBL] [Abstract][Full Text] [Related]
12. Early recurrence in patients undergoing curative resection of colorectal liver oligometastases: identification of its clinical characteristics, risk factors, and prognosis.
Lin J; Peng J; Zhao Y; Luo B; Zhao Y; Deng Y; Sui Q; Gao Y; Zeng Z; Lu Z; Pan Z
J Cancer Res Clin Oncol; 2018 Feb; 144(2):359-369. PubMed ID: 29128882
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
14. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract][Full Text] [Related]
15. Alpha-L-fucosidase as a tumour marker of hepatocellular carcinoma.
Fawzy Montaser M; Amin Sakr M; Omar Khalifa M
Arab J Gastroenterol; 2012 Mar; 13(1):9-13. PubMed ID: 22560818
[TBL] [Abstract][Full Text] [Related]
16. Serum AFU, 5'-NT and AFP as Biomarkers for Primary Hepatocellular Carcinoma Diagnosis.
Junna Z; Gongde C; Jinying X; Xiu Z
Open Med (Wars); 2017; 12():354-358. PubMed ID: 29043300
[TBL] [Abstract][Full Text] [Related]
17. [The value of serum alpha-L-fucosidase activity in the diagnosis of primary liver cancer].
Wei X; Wang S; Rui J
Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):148-50. PubMed ID: 11776645
[TBL] [Abstract][Full Text] [Related]
18. What is the optimal number of neoadjuvant chemotherapy cycles for resectable colorectal liver oligometastases?
Chen Q; Li X; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Zhao H; Cai J
Ann Transl Med; 2021 Jan; 9(1):7. PubMed ID: 33553300
[TBL] [Abstract][Full Text] [Related]
19. Alpha-L-Fucosidase Has Diagnostic Value in Prostate Cancer With "Gray-Zone PSA" and Inhibits Cancer Progression
Zhang C; Liu J; Chao F; Wang S; Li D; Han D; Xu Z; Xu G; Chen G
Front Oncol; 2021; 11():742354. PubMed ID: 34881177
[TBL] [Abstract][Full Text] [Related]
20. Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.
Koie T; Ohyama C; Yamamoto H; Hatakeyama S; Imai A; Yoneyama T; Hashimoto Y; Kitayam M; Hirota K
Urol Oncol; 2014 Aug; 32(6):820-5. PubMed ID: 24951323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
